Cisapride Suspension and Rozlytrek
Determining the interaction of Cisapride Suspension and Rozlytrek and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.CONTRAINDICATED: Cisapride can cause dose-related prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong the QT interval may result in additive effects and increased risk of ventricular arrhythmias including torsade de pointes and sudden death. MANAGEMENT: Coadministration of cisapride with other drugs that can prolong the QT interval is considered contraindicated. References Cerner Multum, Inc. "Australian Product Information." O 0 Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75 "Product Information. Propulsid (cisapride)." Janssen Pharmaceutica, Titusville, NJ. Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251 Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 Canadian Pharmacists Association "e-CPS. Available from: URL: http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink." View all 6 references
Professional:CONTRAINDICATED: Cisapride can cause dose-related prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong the QT interval may result in additive effects and increased risk of ventricular arrhythmias including torsade de pointes and sudden death.
MANAGEMENT: Coadministration of cisapride with other drugs that can prolong the QT interval is considered contraindicated.
- Cerner Multum, Inc. "Australian Product Information." O 0
- Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75
- "Product Information. Propulsid (cisapride)." Janssen Pharmaceutica, Titusville, NJ.
- Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Canadian Pharmacists Association "e-CPS. Available from: URL: http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink."
Generic Name: cisapride
Brand name: Propulsid
Synonyms: Cisapride Tablets
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cisapride Suspension-Ru-Hist Forte
- Cisapride Suspension-Ru-Hist-D
- Cisapride Suspension-Rubella and mumps virus vaccine live Intramuscular
- Cisapride Suspension-Rubella virus vaccine, live Subcutaneous
- Cisapride Suspension-Rubex
- Cisapride Suspension-Rubraca
- Rozlytrek-Cisapride Tablets
- Rozlytrek-Cisatracurium
- Rozlytrek-Cisatracurium Besylate
- Rozlytrek-Cisatracurium Besylate Injection
- Rozlytrek-Cisatracurium besylate Intravenous
- Rozlytrek-Cisplatin